• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种提高开具阿片类药物处方患者纳洛酮可及性的医疗系统层面干预措施。

A Healthcare System-Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions.

机构信息

The MetroHealth System, Cleveland, Ohio.

Case Western Reserve University School of Medicine, Cleveland, Ohio.

出版信息

Am J Addict. 2021 Mar;30(2):179-182. doi: 10.1111/ajad.13136. Epub 2020 Dec 30.

DOI:10.1111/ajad.13136
PMID:33378097
Abstract

BACKGROUND AND OBJECTIVES

National guidelines recommend prescribing naloxone to patients receiving chronic opioids. However, provider adherence to naloxone co-prescribing best practices is poor and knowledge gaps for improvement efforts are large. As part of a system-wide quality improvement intervention to improve opioid safety, we sought to improve access to naloxone for patients with opioid prescriptions.

METHODS

A prompt for naloxone co-prescribing was implemented in the electronic health record. Baseline data and data after implementation were collected for naloxone co-prescribing and fill rates on naloxone prescriptions s (n = 9122 pre, 8368 post).

RESULTS

In the 9 months following the implementation of the electronic prompt, the total number of naloxone prescriptions increased more than 15-fold. Patients prescribed naloxone filled their naloxone prescriptions similarly (42%) before and after the prompt implementation, resulting in a marked increase in the absolute number of patients with access to naloxone. Patient fill rates varied by clinical area (33% emergency medicine to 47% general medicine).

CONCLUSION AND SCIENTIFIC SIGNIFICANCE

An electronic prompt, encouraging providers to prescribe naloxone to at-risk patients led to a marked increase in the percentage of patients with an active naloxone prescription. The availability of naloxone in communities saves lives and this study is the first to demonstrate an intervention, which led to increased naloxone prescribing and reported on actual pharmacy fills of naloxone when co-prescribed with opioids. (Am J Addict 2020;00:00-00).

摘要

背景与目的

国家指南建议向接受慢性阿片类药物治疗的患者开具纳洛酮处方。然而,提供者对纳洛酮共同处方最佳实践的依从性很差,并且改进工作的知识差距很大。作为一项旨在改善阿片类药物安全性的全系统质量改进干预措施的一部分,我们试图增加有阿片类药物处方的患者获得纳洛酮的机会。

方法

在电子健康记录中实施了纳洛酮共同处方提示。在纳洛酮共同处方和纳洛酮处方的填写率方面,收集了实施前(9122 例)和实施后(8368 例)的数据。

结果

在电子提示实施后的 9 个月内,纳洛酮处方的总数增加了 15 倍以上。开具纳洛酮的患者在提示实施前后的纳洛酮处方填写率相似(42%),这导致有纳洛酮的患者数量显著增加。患者的填写率因临床科室而异(急诊 33%,普通内科 47%)。

结论和科学意义

电子提示鼓励提供者为高危患者开具纳洛酮处方,这导致有活性纳洛酮处方的患者比例显著增加。纳洛酮在社区的可及性可以挽救生命,本研究首次证明了一种干预措施可以增加纳洛酮的开具,并报告了当与阿片类药物共同开具时实际的纳洛酮配药情况。(美国成瘾医学杂志 2020 年;00:00-00)

相似文献

1
A Healthcare System-Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions.一种提高开具阿片类药物处方患者纳洛酮可及性的医疗系统层面干预措施。
Am J Addict. 2021 Mar;30(2):179-182. doi: 10.1111/ajad.13136. Epub 2020 Dec 30.
2
Implementing an overdose education and naloxone distribution program in a health system.在一个卫生系统中实施过量用药教育和纳洛酮分发项目。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S154-S160. doi: 10.1016/j.japh.2017.01.002. Epub 2017 Feb 21.
3
Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.阿片类药物安全措施的存在、阿片类药物和纳洛酮的处方模式,以及开具纳洛酮的感知障碍:基于实践类型、范围和地点的横断面调查结果。
J Opioid Manag. 2021 Jan-Feb;17(1):19-38. doi: 10.5055/jom.2021.0611.
4
The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio.阿片类药物处方指南对俄亥俄州急诊医师处方的影响。
Ann Emerg Med. 2017 Dec;70(6):799-808.e1. doi: 10.1016/j.annemergmed.2017.03.057. Epub 2017 May 23.
5
Racial inequities in U.S. naloxone prescriptions.美国纳洛酮处方中的种族不平等现象。
Subst Abus. 2020;41(2):232-244. doi: 10.1080/08897077.2019.1686721. Epub 2019 Nov 13.
6
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
7
US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system.美国使用丁丙诺啡透皮贴剂系统进行新治疗的从业者处方习惯及患者特征。
Curr Med Res Opin. 2014 Aug;30(8):1579-87. doi: 10.1185/03007995.2014.901941. Epub 2014 Apr 4.
8
Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.在为长期接受阿片类药物治疗疼痛的患者提供治疗的初级保健提供者中纳洛酮联合处方的可接受性。
J Gen Intern Med. 2017 Mar;32(3):291-295. doi: 10.1007/s11606-016-3911-z. Epub 2016 Nov 4.
9
Association of Lowering Default Pill Counts in Electronic Medical Record Systems With Postoperative Opioid Prescribing.电子病历系统中降低默认药丸计数与术后阿片类药物处方之间的关联。
JAMA Surg. 2018 Nov 1;153(11):1012-1019. doi: 10.1001/jamasurg.2018.2083.
10
Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis.《萨斯卡通地区急诊部阿片类药物处方指南对急诊医师行为和用药过量发生率的影响:回顾性实施前后分析》
CMAJ Open. 2021 Jan 29;9(1):E79-E86. doi: 10.9778/cmajo.20200071. Print 2021 Jan-Mar.

引用本文的文献

1
Academic Detailing to Enhance Adoption of Clinical Decision Support for Patients at Risk of Opioid Overdose.学术推广以提高对阿片类药物过量风险患者临床决策支持的采用率。
Appl Clin Inform. 2025 Mar;16(2):393-401. doi: 10.1055/a-2508-7086. Epub 2025 May 7.
2
Iterative Development of a Clinical Decision Support Tool to Enhance Naloxone Coprescribing.用于加强纳洛酮联合处方的临床决策支持工具的迭代开发。
Appl Clin Inform. 2025 Jan;16(1):215-222. doi: 10.1055/a-2447-8463. Epub 2024 Oct 25.
3
Naloxone co-prescriptions for surgery patients prescribed opioids: A retrospective cohort study.
接受阿片类药物治疗的手术患者的纳洛酮联合处方:一项回顾性队列研究。
Surg Pract Sci. 2023 Dec;15. doi: 10.1016/j.sipas.2023.100217. Epub 2023 Sep 11.
4
Experiences and Outcomes of Using e-Prescribing for Opioids: Rapid Scoping Review.电子处方开具阿片类药物的经验和结果:快速范围综述。
J Med Internet Res. 2023 Dec 28;25:e49173. doi: 10.2196/49173.
5
Opioid Prescribing for Chronic Musculoskeletal Conditions: Trends over Time and Implementation of Safe Opioid-Prescribing Practices.慢性肌肉骨骼疾病的阿片类药物处方:随时间的变化趋势和安全阿片类药物处方实践的实施情况。
Appl Clin Inform. 2023 Oct;14(5):961-972. doi: 10.1055/s-0043-1776879. Epub 2023 Dec 6.
6
Enhancing research data infrastructure to address the opioid epidemic: the Opioid Overdose Network (O2-Net).加强研究数据基础设施以应对阿片类药物流行:阿片类药物过量网络(O2-Net)。
JAMIA Open. 2022 Jun 30;5(2):ooac055. doi: 10.1093/jamiaopen/ooac055. eCollection 2022 Jul.
7
A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement.一项针对一年级医学生的纳洛酮阿片类药物过量意识和逆转培训的纵向研究:需要加强具体内容。
Harm Reduct J. 2022 Jul 2;19(1):70. doi: 10.1186/s12954-022-00656-y.
8
Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.药店纳洛酮共调配:一项在全州范围内的常备处方项目下的实践和观点的混合方法研究。
J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1546-1554. doi: 10.1016/j.japh.2022.03.015. Epub 2022 Mar 19.
9
Naloxone prescribing practices in the Military Health System before and after policy implementation.政策实施前后军事卫生系统中纳洛酮的处方实践。
Pain Rep. 2021 Mar 14;7(2):e993. doi: 10.1097/PR9.0000000000000993. eCollection 2022 Mar-Apr.